Ambrx Biopharma American Price History

AMAMDelisted Stock  USD 15.73  0.71  4.73%   
If you're considering investing in Ambrx Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ambrx Biopharma stands at 15.73, as last reported on the 26th of November, with the highest price reaching 15.99 and the lowest price hitting 14.91 during the day. We have found thirty technical indicators for Ambrx Biopharma American, which you can use to evaluate the volatility of the firm. Please confirm Ambrx Biopharma's risk adjusted performance of 0.097, and Mean Deviation of 3.64 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Ambrx Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
AMAM
Based on monthly moving average Ambrx Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ambrx Biopharma by adding Ambrx Biopharma to a well-diversified portfolio.

Ambrx Biopharma Stock Price History Chart

There are several ways to analyze Ambrx Stock price data. The simplest method is using a basic Ambrx candlestick price chart, which shows Ambrx Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Ambrx Stock Price History Data

The price series of Ambrx Biopharma for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 7.52 with a coefficient of variation of 14.71. The prices are distributed with arithmetic mean of 13.75. The median price for the last 90 days is 14.41. The company had 1:1 stock split on 12th of October 2023.
OpenHighLowCloseVolume
11/26/2024
 15.02  15.99  14.91  15.73 
07/24/2023 15.02  15.99  14.91  15.73  302,158 
07/21/2023 15.00  15.11  14.61  15.03  334,547 
07/20/2023 15.96  16.03  15.14  15.30  197,631 
07/19/2023 15.67  16.15  15.43  15.84  296,416 
07/18/2023 14.79  15.86  14.79  15.74  236,863 
07/17/2023 14.71  15.22  14.49  14.91  125,978 
07/14/2023 14.05  15.01  13.78  14.73  188,685 
07/13/2023 13.70  14.08  13.62  13.94  215,378 
07/12/2023 13.33  14.12  13.16  13.55  446,332 
07/11/2023 14.51  14.85  13.26  13.27  489,018 
07/10/2023 15.00  15.22  14.43  14.56  471,172 
07/07/2023 16.10  16.37  14.76  15.15  486,442 
07/06/2023 16.47  16.52  15.89  16.34  297,523 
07/05/2023 16.17  16.86  15.74  16.60  361,430 
07/03/2023 16.59  16.59  15.91  16.16  163,269 
06/30/2023 16.34  16.63  16.16  16.46  264,643 
06/29/2023 16.17  16.64  15.82  16.31  295,765 
06/28/2023 16.21  16.58  15.70  16.10  299,441 
06/27/2023 16.07  16.55  15.90  16.21  287,112 
06/26/2023 15.31  16.07  15.24  15.96  237,388 
06/23/2023 15.90  16.00  15.31  15.39  207,892 
06/22/2023 15.88  16.15  15.41  15.90  196,061 
06/21/2023 16.23  16.42  15.20  16.03  419,639 
06/20/2023 15.01  16.29  14.69  16.10  496,554 
06/16/2023 14.70  15.46  14.50  15.01  384,928 
06/15/2023 14.42  14.95  13.92  14.67  277,244 
06/14/2023 14.90  15.10  14.50  14.56  203,013 
06/13/2023 14.24  14.83  13.93  14.52  221,162 
06/12/2023 14.70  14.90  14.23  14.51  351,875 
06/09/2023 14.40  14.98  14.23  14.70  305,159 
06/08/2023 13.62  14.73  13.34  14.41  434,084 
06/07/2023 12.69  13.85  11.82  13.68  714,148 
06/06/2023 13.28  13.81  12.51  12.90  561,041 
06/05/2023 14.67  14.90  13.03  13.27  668,991 
06/02/2023 15.25  15.25  14.36  14.92  365,702 
06/01/2023 14.69  15.06  14.09  14.53  337,033 
05/31/2023 14.90  15.00  14.39  14.76  408,410 
05/30/2023 14.05  15.00  13.57  14.81  423,269 
05/26/2023 14.08  14.67  13.59  14.01  475,975 
05/25/2023 15.00  15.00  13.88  14.03  562,218 
05/24/2023 13.96  15.29  13.58  14.97  1,129,003 
05/23/2023 13.54  15.09  13.54  14.23  701,994 
05/22/2023 12.89  13.66  12.89  13.48  264,280 
05/19/2023 14.25  14.25  12.87  13.00  438,104 
05/18/2023 14.38  14.60  13.50  13.77  701,702 
05/17/2023 14.24  14.48  13.06  14.35  1,481,041 
05/16/2023 12.08  13.78  11.62  13.60  1,693,890 
05/15/2023 11.68  12.17  11.41  12.06  863,766 
05/12/2023 11.20  11.64  10.81  11.64  148,810 
05/11/2023 11.51  11.75  11.18  11.29  258,082 
05/10/2023 11.65  12.07  11.39  11.69  315,351 
05/09/2023 11.57  11.96  11.21  11.88  196,411 
05/08/2023 11.77  12.16  10.94  11.82  500,710 
05/05/2023 11.90  12.50  11.51  11.78  480,633 
05/04/2023 11.56  11.93  11.05  11.83  547,787 
05/03/2023 9.77  11.95  9.77  11.64  800,858 
05/02/2023 9.94  10.04  9.16  9.79  287,182 
05/01/2023 9.65  10.53  9.65  9.92  261,644 
04/28/2023 9.44  9.75  9.21  9.64  143,559 
04/27/2023 9.16  9.83  8.90  9.61  224,667 

About Ambrx Biopharma Stock history

Ambrx Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ambrx is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ambrx Biopharma American will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ambrx Biopharma stock prices may prove useful in developing a viable investing in Ambrx Biopharma
Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. The company was incorporated in 2003 and is headquartered in La Jolla, California. Ambrx Biopharma operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 81 people.

Ambrx Biopharma Stock Technical Analysis

Ambrx Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Ambrx Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ambrx Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Ambrx Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Ambrx Biopharma's price direction in advance. Along with the technical and fundamental analysis of Ambrx Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ambrx to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Consideration for investing in Ambrx Stock

If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.